/ about us / technology / news / contact us
	May 19, 2011 Jenken Biosciences U.S. Patent Allowed for Compounds To Treat Crohn’s Disease April 12, 2011 Jenken Biosciences Granted Patent for Morphinans Including NCE Lead to Treat RA, MS, CD, and Organ Damages December 30, 2010 Jenken Biosciences Amended Its Phase II trial protocol to a Two-Stage Adaptive Trial Design March 28, 2009 Jenken Biosciences Granted Key Patent for Compounds To Treat Chronic Liver and Kidney Diseases July 12, 2007 Jenken Biosciences Receives $142,716 for Preclinical Work December 14, 2006 Jenken Biosciences receives FDA clearance for Phase II trial of lead compound
	Copyright © 2008 Jenken Biosciences. All Rights Reserved